1. Actors, Hollywood studios reach deal to end strike
SAG-AFTRA, the union representing striking actors, reached a tentative agreement with Hollywood studios on Wednesday to end the 118-day actors strike. A SAG-AFTRA committee approved the proposed three-year contract deal unanimously, ending the strike at 12:01 a.m. Thursday. The union's national board will sign off on Friday. The agreement cleared the way "for the $134 billion American movie and television business to swing back into motion," The New York Times reported. The proposed contract includes pay increases, a "streaming participation bonus" and regulations on the use of artificial intelligence. Concerns about potential use of AI to create digital replicas of actors' images without pay or consent was a key issue in the walkout. The Hollywood Reporter, The New York Times
2. Disney profits beat expectations
Walt Disney Co. announced stronger-than-expected quarterly profits on Wednesday and said it added five million subscribers to its Disney+ streaming service. CEO Robert Iger said the entertainment giant still had "work to do" but had made strides in reorganizing itself. "These efforts have allowed us to move beyond this period of fixing and begin building our businesses again," Iger said. Disney said profits increased to $694 million in the third quarter, compared to $254 million in the same period last year. Disney's parks and cruises division increased its operating profit by 30% from the same period in 2022. The New York Times, NPR
3. FDA approves Eli Lilly weight loss drug
The Food and Drug Administration approved pharmaceutical company Eli Lilly's new weight loss drug, Zepbound, on Wednesday. The drug helped people lose up to 52 pounds over 16 months in clinical trials. Zepbound is the latest in a wave of new drugs like Novo Nordisk's Ozempic and Wegovy and Lilly's Mounjaro that offer new options for fighting obesity. Lilly said Zepbound would be available in the United States by the end of 2023 at $1,060 for a monthly supply. The treatment could be out of reach for many people, though, because lots of insurers hesitate to cover weight loss drugs and Medicare can't, by law. NBC News
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
4. S&P 500 futures inch up after index extends winning streak
S&P 500 futures edged higher early Thursday after the broad-market index extended its longest winning streak since November 2021. Futures tied to the S&P 500 and the Dow Jones Industrial Average were up 0.1% at 7 a.m. ET. Nasdaq futures were down 0.1%. Disney shares rose 2% after the entertainment powerhouse reported better-than-expected quarterly profits, while Lyft shares fell nearly 2% after the rideshare platform reported disappointing bookings. The S&P 500 gained 0.1% on Wednesday, extending its winning streak to eight days. The tech-heavy Nasdaq made similar gains to post its ninth straight positive day, its longest streak in two years. The Dow edged down 0.1% on Wednesday, snapping a seven-day winning streak. CNBC
5. Amazon to offer Prime subscribers low-cost One Medical membership
Amazon on Wednesday announced a plan to offer Amazon Prime subscribers a low-cost membership to its One Medical health care business. Amazon bought One Medical, a primary-care business, for $3.9 billion earlier this year. The online retail giant charges $199 annually for One Medical memberships, but said it would offer the service to Prime subscribers for $9 a month, or $99 per year. The effort to tap into the company's millions of Prime subscribers to boost One Medical marked Amazon's latest push to grow its health care business, which also includes pharmacy services. Amazon has made several efforts to break into health care, which CEO Andy Jassy and other Amazon executives have said could one day become a key business for the company. The Wall Street Journal
-
What to know before turning to AI for financial advicethe explainer It can help you crunch the numbers — but it might also pocket your data
-
Book reviews: 'The Headache: The Science of a Most Confounding Affliction—and a Search for Relief' and 'Tonight in Jungleland: The Making of Born to Run'Feature The search for a headache cure and revisiting Springsteen's 'Born to Run' album on its 50th anniversary
-
Keith McNally' 6 favorite books that have ambitious charactersFeature The London-born restaurateur recommends works by Leo Tolstoy, John le Carré, and more
-
NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B dealSpeed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
A potential railway megamerger raises monopoly questionsThe Explainer Union Pacific and Norfolk Southern would create the country's largest railway operator
-
AMC hopes new ticket discounts will reinvigorate the movie theater industryIn the Spotlight The theater chain now has 50% discounts on both Tuesdays and Wednesdays
-
The FTC is pushing back against false 'Made in the USA' claimsThe Explainer The agency has dubbed July 2025 'Made in the USA' month
-
Higher toy prices from Trump's tariffs have arrivedIn the Spotlight Three out of four toy products in the US come from China
-
'Wrench attacks' are targeting wealthy crypto mogulsThe Explainer The attacks are named for physical coercion that can be used to gain crypto passwords
-
Trump is trying to jump-start US manufacturing. Is it worth it?Today's Big Question The jobs are good. The workers may not be there.
